The coronavirus pandemic has infected more than 36.0 million people and killed more than 1,050,000 worldwide since late January, when it was first reported. The outbreak spread from the Chinese city of Wuhan to more than 180 countries and territories—affecting every continent except Antarctica. Efforts to stamp out the pneumonia-like illness have led to entire nations enforcing lockdowns, widespread halts of international travel, mass layoffs and battered financial markets.
Getting to a Flatter Curve
The first 264 days with more than 100 confirmed cases.
Note: JHU CSSE reporting began on Jan. 22, when mainland China had already surpassed 500 cases. Source: Johns Hopkins University Center for Systems Science and Engineering 36,077,017 Confirmed cases worldwide 1,054,674 Deaths worldwide Jurisdictions with cases confirmed as of October 8, 2020, 2:24 PM GMT+11.
Note: Totals for Denmark, France, the Netherlands, the U.K., and the U.S. include overseas territories and other dependencies. Cases and deaths for cruise ships have been separated in accordance with JHU CSSE data.
More Coverage From Bloomberg
- Sign up for our daily coronavirus newsletter
- Virus Update from Bloomberg News
- Stories about the coronavirus outbreak from Bloomberg News
- Why Acting Fast Is the Key to Beating a Second Wave of Covid-19
- What You Need to Know About the Spreading Coronavirus: QuickTake
- The Future of Travel in the Covid Era
- How Covid Is Shifting Human Behavior Around the World
The epicenter of the pandemic has continued to shift throughout the year. The first one was in China, then it shifted to Europe. Now the virus is surging in developing countries like Brazil and India. Since late March, the U.S. has had the most infections globally—accounting for a quarter of the world’s confirmed cases and deaths.
Global Cases Added Per Day
Countries took drastic measures to mitigate the spread of COVID-19 on their homefront—with varying degrees of success. More than 140 governments placed blanket bans on incoming travelers, closed schools and restricted gatherings and public events, according to data compiled by Oxford University’s Blavatnik School of Government and Bloomberg reporting.
As countries loosen lockdowns in an effort to reboot their economies, many have seen a resurgence of infections. The number of new daily cases in the U.S. rose to record highs after some states relaxed social distancing requirements. Even places that successfully contained infections earlier in the year, like China and South Korea, have seen cases bubble back up. Theories that warmer weather in the Northern Hemisphere would bring relief appear to be unfounded.
The “worst is yet to come” given a lack of global solidarity, Tedros Adhanom Ghebreyesus, head of the World Health Organization, said at a briefing in Geneva on June 29.
In May, the WHO emphasized the need for a plan that includes testing for the virus and its antibodies, effective contact tracing and isolation, and community education. Antibody tests on the market that could potentially indicate a person’s immunity have been unreliable so far. Researchers and drugmakers are racing to develop treatments and vaccines that could hold the key to recovery.
Gilead Sciences Inc.’s antiviral remdesivir is one of the first widely used drugs for Covid-19. It received an emergency use authorization from U.S. regulators in May, after a big trial found it sped recovery by about four days in hospitalized patients.
A cheap, widely used anti-inflammatory drug called dexamethasone was found to reduce deaths by a third among patients on ventilators and by a fifth among those receiving oxygen only, according to researchers at the University of Oxford. It’s the first treatment to show life-saving promise.
First published at Bloomberg News – Thursday 8 October 2020. See; https://www.bloomberg.com/graphics/2020-coronavirus-cases-world-map/?srnd=premium-asia